BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 22882907)

  • 21. CD40-targeting magnetic nanoparticles for MRI/optical dual-modality molecular imaging of vulnerable atherosclerotic plaques.
    Wu Q; Pan W; Wu G; Wu F; Guo Y; Zhang X
    Atherosclerosis; 2023 Mar; 369():17-26. PubMed ID: 36863196
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo assessment of intraplaque and endothelial fibrin in ApoE(-/-) mice by molecular MRI.
    Makowski MR; Forbes SC; Blume U; Warley A; Jansen CH; Schuster A; Wiethoff AJ; Botnar RM
    Atherosclerosis; 2012 May; 222(1):43-9. PubMed ID: 22284956
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Negative MR contrast caused by USPIO uptake in lymph nodes may lead to false positive observations with in vivo visualization of murine atherosclerotic plaque.
    te Boekhorst BC; Bovens SM; Nederhoff MG; van de Kolk KW; Cramer MJ; van Oosterhout MF; Ten Hove M; Doevendans PA; Pasterkamp G; van Echteld CJ
    Atherosclerosis; 2010 May; 210(1):122-9. PubMed ID: 19939385
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Magnetic resonance imaging of experimental atherosclerotic plaque: comparison of two ultrasmall superparamagnetic particles of iron oxide.
    Herborn CU; Vogt FM; Lauenstein TC; Dirsch O; Corot C; Robert P; Ruehm SG
    J Magn Reson Imaging; 2006 Aug; 24(2):388-93. PubMed ID: 16791857
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dual-probe molecular MRI for the in vivo characterization of atherosclerosis in a mouse model: Simultaneous assessment of plaque inflammation and extracellular-matrix remodeling.
    Reimann C; Brangsch J; Kaufmann JO; Adams LC; Onthank DC; Thöne-Reineke C; Robinson SP; Hamm B; Botnar RM; Makowski MR
    Sci Rep; 2019 Sep; 9(1):13827. PubMed ID: 31554825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surface-Functionalized Nanoparticles by Olefin Metathesis: A Chemoselective Approach for In Vivo Characterization of Atherosclerosis Plaque.
    Salinas B; Ruiz-Cabello J; Lechuga-Vieco AV; Benito M; Herranz F
    Chemistry; 2015 Jul; 21(29):10450-6. PubMed ID: 26096657
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MRI of inducible P-selectin expression in human activated platelets involved in the early stages of atherosclerosis.
    Jacobin-Valat MJ; Deramchia K; Mornet S; Hagemeyer CE; Bonetto S; Robert R; Biran M; Massot P; Miraux S; Sanchez S; Bouzier-Sore AK; Franconi JM; Duguet E; Clofent-Sanchez G
    NMR Biomed; 2011 May; 24(4):413-24. PubMed ID: 21192086
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Magnetic resonance imaging of vulnerable atherosclerotic plaques: current imaging strategies and molecular imaging probes.
    Briley-Saebo KC; Mulder WJ; Mani V; Hyafil F; Amirbekian V; Aguinaldo JG; Fisher EA; Fayad ZA
    J Magn Reson Imaging; 2007 Sep; 26(3):460-79. PubMed ID: 17729343
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of lipid-rich aortic plaques by intravascular photoacoustic tomography: ex vivo and in vivo validation in a rabbit atherosclerosis model with histologic correlation.
    Zhang J; Yang S; Ji X; Zhou Q; Xing D
    J Am Coll Cardiol; 2014 Jul; 64(4):385-90. PubMed ID: 25060374
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improved in vivo detection of atherosclerotic plaques with a tissue factor-targeting magnetic nanoprobe.
    Wei Q; Wang J; Shi W; Zhang B; Jiang H; Du M; Mei H; Hu Y
    Acta Biomater; 2019 May; 90():324-336. PubMed ID: 30954623
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of vulnerable atherosclerosis plaques with a dual-modal single-photon-emission computed tomography/magnetic resonance imaging probe targeting apoptotic macrophages.
    Cheng D; Li X; Zhang C; Tan H; Wang C; Pang L; Shi H
    ACS Appl Mater Interfaces; 2015 Feb; 7(4):2847-55. PubMed ID: 25569777
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-inflammatory drug evaluation in ApoE-/- mice by ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging.
    Sigovan M; Kaye E; Lancelot E; Corot C; Provost N; Majd Z; Breisse M; Canet-Soulas E
    Invest Radiol; 2012 Sep; 47(9):546-52. PubMed ID: 22864378
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tropoelastin: A novel marker for plaque progression and instability.
    Phinikaridou A; Lacerda S; Lavin B; Andia ME; Smith A; Saha P; Botnar RM
    Circ Cardiovasc Imaging; 2018 Aug; 11(8):. PubMed ID: 30214669
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improved characterization of atherosclerotic plaques by gadolinium contrast during intravascular magnetic resonance imaging of human arteries.
    Larose E; Kinlay S; Selwyn AP; Yeghiazarians Y; Yucel EK; Kacher DF; Libby P; Ganz P
    Atherosclerosis; 2008 Feb; 196(2):919-25. PubMed ID: 17391676
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nanoparticles functionalised with an anti-platelet human antibody for in vivo detection of atherosclerotic plaque by magnetic resonance imaging.
    Jacobin-Valat MJ; Laroche-Traineau J; Larivière M; Mornet S; Sanchez S; Biran M; Lebaron C; Boudon J; Lacomme S; Cérutti M; Clofent-Sanchez G
    Nanomedicine; 2015 May; 11(4):927-37. PubMed ID: 25684334
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo MRI detection of carotid atherosclerotic lesions and kidney inflammation in ApoE-deficient mice by using LOX-1 targeted iron nanoparticles.
    Wen S; Liu DF; Cui Y; Harris SS; Chen YC; Li KC; Ju SH; Teng GJ
    Nanomedicine; 2014 Apr; 10(3):639-49. PubMed ID: 24103305
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular imaging of atherosclerosis with nanoparticle-based fluorinated MRI contrast agents.
    Palekar RU; Jallouk AP; Lanza GM; Pan H; Wickline SA
    Nanomedicine (Lond); 2015; 10(11):1817-32. PubMed ID: 26080701
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contrast enhancement by lipid-based MRI contrast agents in mouse atherosclerotic plaques; a longitudinal study.
    den Adel B; van der Graaf LM; Que I; Strijkers GJ; Löwik CW; Poelmann RE; van der Weerd L
    Contrast Media Mol Imaging; 2013; 8(1):63-71. PubMed ID: 23109394
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incorporation of an apoE-derived lipopeptide in high-density lipoprotein MRI contrast agents for enhanced imaging of macrophages in atherosclerosis.
    Chen W; Vucic E; Leupold E; Mulder WJ; Cormode DP; Briley-Saebo KC; Barazza A; Fisher EA; Dathe M; Fayad ZA
    Contrast Media Mol Imaging; 2008; 3(6):233-42. PubMed ID: 19072768
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rapid-clearance iron nanoparticles for inflammation imaging of atherosclerotic plaque: initial experience in animal model.
    Sigovan M; Boussel L; Sulaiman A; Sappey-Marinier D; Alsaid H; Desbleds-Mansard C; Ibarrola D; Gamondès D; Corot C; Lancelot E; Raynaud JS; Vives V; Laclédère C; Violas X; Douek PC; Canet-Soulas E
    Radiology; 2009 Aug; 252(2):401-9. PubMed ID: 19703881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.